Erasca, Inc. (ERAS) vs Oruka Therapeutics, Inc. (ORKA)
- Erasca, Inc. ERAS 13.39 −9.95%
- Oruka Therapeutics, Inc. ORKA 71.93 −2.63%
Erasca, Inc. and Oruka Therapeutics, Inc. are both Biotechnology companies. Erasca, Inc. and Oruka Therapeutics, Inc. are of similar size ($5.2B and $4.9B). Across the 9 metrics below, Oruka Therapeutics, Inc. leads on 8 and Erasca, Inc. on 1.
Valuation
Profitability
| Metric | ERAS | ORKA | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (78.25%) | (18.30%) | (56.36%) |
| Return on assets | (65.25%) | (17.76%) | (48.04%) |
| Return on invested capital | (203.13%) | (40.22%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack